Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wajahat Z Mehal

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|May 10, 2016
The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice liversMohamed E Shaker, Bobby N Trawick, Wajahat Z Mehal
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2010
A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liverAlexander Zipprich, Wajahat Z Mehal, Cristina Ripoll, et al.
Annals of Gastroenterology and Digestive Disorders|December 15, 2023
Pharmacologic Management of Obesity after Liver Transplantation: A Critical ReviewFrhaan Zahrawi, Sawsan Fathma, Wajahat Z Mehal, et al.
Pancreas|March 15, 2012
Sterile inflammatory response in acute pancreatitisRafaz Hoque, Ahsan F Malik, Fred Gorelick, et al.
Npj Metabolic Health and Disease|September 18, 2025
GLP-1 receptor agonism results in reduction in hepatic ethanol metabolismFrhaan Zahrawi, Arumugam Suyavaran, Bubu A Banini, et al.
Hepatology (Baltimore, Md.)|April 17, 2019
Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic SteatohepatitisAlbert Do, Eric J Kuszewski, Karl A Langberg, et al.
International Immunology|April 13, 2005
TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactionsWajahat Z Mehal, Shehzad Z Sheikh, Leonid Gorelik, et al.
Cell Metabolism|August 28, 2024
Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver diseaseKitt Falk Petersen, Sylvie Dufour, Wajahat Z Mehal, et al.
World Journal of Gastroenterology|April 10, 2023
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disordersFatima Jamshed, Farzaneh Dashti, Xinshou Ouyang, et al.
Expert Opinion on Drug Discovery|October 22, 2020
Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpointsAlbert Do, Ysabel C Ilagan-Ying, Wajahat Z Mehal, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|May 10, 2016
The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice liversMohamed E Shaker, Bobby N Trawick, Wajahat Z Mehal
Liver International : Official Journal of the International Association for the Study of the Liver|May 27, 2010
A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liverAlexander Zipprich, Wajahat Z Mehal, Cristina Ripoll, et al.
Annals of Gastroenterology and Digestive Disorders|December 15, 2023
Pharmacologic Management of Obesity after Liver Transplantation: A Critical ReviewFrhaan Zahrawi, Sawsan Fathma, Wajahat Z Mehal, et al.
Pancreas|March 15, 2012
Sterile inflammatory response in acute pancreatitisRafaz Hoque, Ahsan F Malik, Fred Gorelick, et al.
Npj Metabolic Health and Disease|September 18, 2025
GLP-1 receptor agonism results in reduction in hepatic ethanol metabolismFrhaan Zahrawi, Arumugam Suyavaran, Bubu A Banini, et al.
Hepatology (Baltimore, Md.)|April 17, 2019
Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic SteatohepatitisAlbert Do, Eric J Kuszewski, Karl A Langberg, et al.
International Immunology|April 13, 2005
TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactionsWajahat Z Mehal, Shehzad Z Sheikh, Leonid Gorelik, et al.
Cell Metabolism|August 28, 2024
Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver diseaseKitt Falk Petersen, Sylvie Dufour, Wajahat Z Mehal, et al.
World Journal of Gastroenterology|April 10, 2023
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disordersFatima Jamshed, Farzaneh Dashti, Xinshou Ouyang, et al.
Expert Opinion on Drug Discovery|October 22, 2020
Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpointsAlbert Do, Ysabel C Ilagan-Ying, Wajahat Z Mehal, et al.
Pageof 6